Free shipping on all orders over $ 500

ZLN005

Cat. No. M2335

All AbMole products are for research use only, cannot be used for human consumption.

ZLN005 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
5mg USD 30  USD30 In stock
10mg USD 50  USD50 In stock
50mg USD 180  USD180 In stock
100mg USD 270  USD270 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

ZLN005 is a novel transcriptional regulator of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). ZLN005 stimulates the expression of PGC-1α and downstream genes in skeletal muscle cells, improving glucose utilization and fatty acid oxidation at a concentration of 20 μM. ZLN005 increased PGC-1α and downstream gene transcription in skeletal muscle, whereas hepatic PGC-1α and gluconeogenesis genes were reduced. ZLN005 increased fat oxidation and improved the glucose tolerance, pyruvate tolerance, and insulin sensitivity of diabetic db/db mice. ZLN005 selectively elevated the expression of PGC-1α in myotubes and skeletal muscle and exerted promising therapeutic effects for treating type 2 diabetes.

Product Citations
Customer Product Validations & Biological Datas
Source Diabetes (2013). Figure 1. ZLN005
Method qRT-PCR
Cell Lines HEK293 cells
Concentrations 10 μmol/L
Incubation Time 24 h
Results The mRNA levels of GLUT4, NRF1, estrogen-related receptor a (ERRa), cytochrome c oxidase 5b (cox5b), and acyl-CoA oxidase were increased by ZLN005 (10 μmol/L).
Chemical Information
Molecular Weight 250.34
Formula C17H18N2
CAS Number 49671-76-3
Solubility (25°C) DMSO 35 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Zhang LN, et al. Diabetes. Novel small-molecule PGC-1α transcriptional regulator with beneficial effects on diabetic db/db mice.

Related PPAR Products
GQ-16 

GQ-16 is a moderate affinity ligand for the ligand-binding domain (LBD) of PPARγ, exhibiting a Ki of 160 nM.

SR10221 

SR10221, a noncovalent inverse agonist of PPARγ, represses downstream PPARγ target genes leading to growth inhibition in bladder cancer cell lines.

Amorfrutin B 

Amorfrutin B is a highly potent natural peroxisome proliferation-activated receptor γ (PPARγ) agonist with oral activity with Ki values of 19 nM and EC50 values of 73 nM, respectively.

Netoglitazone

Netoglitazone is a dual agonist of PPARα and PPARγ with antihyperglycemic activity.

DSO-5a

DSO-5a is a potent, selective, orally active BB3 agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: ZLN005 supplier, PPAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.